Amgen slips as Cantor cites safety concerns linked to obesity candidate

Amgen office building in Mississauga, Ontario, Canada.

JHVEPhoto/iStock Editorial via Getty Images

Amgen (NASDAQ:AMGN) shares fell in late afternoon trading Tuesday after Cantor Fitzgerald argued that a potential loss of bone mineral density could be a safety risk linked to its obesity candidate MariTide (AMG-133).

According to investors and analysts, the experimental therapy

Leave a Reply

Your email address will not be published. Required fields are marked *